Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia
AbstractVentilator-associated pneumonia (VAP) is the most common infectious complication in the intensive care unit. It can increase duration of mechanical ventilation, length of stay, costs, and mortality. Improvements in the administration of empirical antibiotic therapy have potential to reduce the complications of VAP. This review will discuss the current data addressing empirical antibiotic therapy and the effect on mortality in patients with VAP. It will also address factors that could improve the administration of empirical antibiotics and directions for future research.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Swanson, J.M.; Wells, D.L. Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia. Antibiotics 2013, 2, 339-351.
Swanson JM, Wells DL. Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia. Antibiotics. 2013; 2(3):339-351.Chicago/Turabian Style
Swanson, Joseph M.; Wells, Diana L. 2013. "Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia." Antibiotics 2, no. 3: 339-351.